An Open-Label, Phase II Safety, Tolerability, Drug Level and Efficacy Trial of Quinacrine in Patients With Androgen-Independent Metastatic Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2013
At a glance
- Drugs Mepacrine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 10 Apr 2013 Priamry endpoint amended as reported by ClinicalTrials.gov record.
- 01 May 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.